May 2015 Health Product InfoWatch now available

The May 2015 issue of Health Product InfoWatch (formerly Adverse Reaction Newsletter), published by the Marketed Health Products Directorate, Health Products and Food Branch, is now available. This newsletter is a monthly publication providing safety information on pharmaceuticals, biologics, medical devices and natural health products.

In this issue:

Monthly recap
Review article: Febuxostat and international reports of agranulocytosis and drug rash with eosinophilia and systemic symptoms (DRESS)
Product monograph update: Nexavar (sorafenib)

Keep Reading

Do you have a new pharmacist graduate on your team?

June 10, 2025

Licensees: Ensure new pharmacist grads are listed on the clinical pharmacist register before practising independently.

Improving policies and procedures helps reduce practice incidents

June 10, 2025

Improve is the fourth key activity of CQI+.

Unauthorized compounding of semaglutide-containing products is not permitted

June 10, 2025

Health Canada’s position on the unauthorized manufacturing of products sold as compounded glucagon like peptide 1 (GLP-1) receptor agonists.

Find a registrant or pharmacy

Search the website

Help me with...

Prescriber Lists

Share:

Keep Reading

Do you have a new pharmacist graduate on your team?

Improving policies and procedures helps reduce practice incidents

Unauthorized compounding of semaglutide-containing products is not permitted

Registrant information

Registrant place of work

Registrant position

Authorizations

Pharmacy information

Pharmacy Address